| 产品名称 | Voriconazole - Vfend | UK 109496 |
| 产品货号 | Axon 2044 CAS [137234-62-9] MF C16H14F3N5OMW 349.31 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Orally bioavailable CYP51 inhibitor; Antifungal agent; Voriconazole binds and inhibits ergosterol synthesis by inhibiting CYP450-dependent 14-α sterol demethylase (CYP51, P450-DM), resulting in a depletion of ergosterol in fungal cell membrane. References Certificates Categories Extra info L.J. Scott et al. Voriconazole : a review of its use in the management of invasive fungal infections. Drugs. 2007, 67, 269-298. M. Sandherr et al. Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature. Eur. J. Med. Res. 2011, 16, 139-144. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Diabetes & Metabolism Immunology EC 1.14.13.70 Cytochrome P450 Pfizer Licensed Products Orally bioavailable CYP51 inhibitor; Antifungal agent Chemical name (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [137234-62-9] Order Size Unit Price Stock 10 mg €95.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Voriconazole - Vfend | UK 109496Axon 2044 CAS [137234-62-9] MF C16H14F3N5O
Description
Orally bioavailable CYP51 inhibitor; Antifungal agent; Voriconazole binds and inhibits ergosterol synthesis by inhibiting CYP450-dependent 14-α sterol demethylase (CYP51, P450-DM), resulting in a depletion of ergosterol in fungal cell membrane.
Orally bioavailable CYP51 inhibitor; Antifungal agent
Chemical name(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[137234-62-9] |
| 产品资料 |
